glp 1 wirkung GLP-1 ist mehr als ein Antidiabetikum | InFo Diabetologie Ensuring Quality and Efficacy of

Vilsbll et al

market in February

Furthermore, several key baseline characteristics were also different between the two study populations

Keeping Your Muscle When you lose weight rapidly, you often lose muscle along with fat

Antidiabetic agents and risk of atrial fibrillation/flutter: a comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists

doi: 10.3389/fcdhc.2023.1293926 Received 13 September 2023 Accepted 16 November 2023 Published 08 December 2023 Volume 4 - 2023 Edited by Azra Durak-Nalbantic, Clinical Center University of Sarajevo, Bosnia and Herzegovina Reviewed by Edin Begic, Sarajevo School of Science and Technology, Bosnia and Herzegovina Updates Copyright 2023 Ferhatbegovi, Mri and Maci-Dankovi